Recent advances in triazoles as tyrosinase inhibitors.
1,2,3-Triazole
1,2,4-Triazole
Structure-activity relationship
Tyrosinase inhibitors
Journal
European journal of medicinal chemistry
ISSN: 1768-3254
Titre abrégé: Eur J Med Chem
Pays: France
ID NLM: 0420510
Informations de publication
Date de publication:
05 Nov 2023
05 Nov 2023
Historique:
received:
30
05
2023
revised:
10
07
2023
accepted:
13
07
2023
medline:
22
8
2023
pubmed:
24
7
2023
entrez:
23
7
2023
Statut:
ppublish
Résumé
The tyrosinase enzyme, which is widely found in microorganisms, animals and plants, has a significant position in melanogenesis, plays an important role in undesirable browning of fruits and vegetables, antibiotic resistance, skin pigment formation, sclerotization of cuticle, neurodegeneration, etc. Therefore, with the wide potential application fields of tyrosinase in food, agriculture, cosmetics and pharmaceutical industries, which has become the target enzyme for the development of therapeutic agents such as antibrowning, anticancer, antibacterial, skin whitening, insecticides, etc., a large number of synthetic tyrosinase inhibitors have been widely reported in recent years. The triazole ring, which has a broad spectrum of biological action, is of increasing interest in the synthesis of new tyrosinase inhibitors. In this review, tyrosinase inhibition effects, structure-activity relationships, enzyme inhibition kinetics and mechanisms of action of 1,2,3- or 1,2,4-triazole derivatives were investigated. The data gathered is anticipated to supply rational guidance and an influential strategy for the development of novel, potent and safe tyrosinase inhibitors for better practical application in the future.
Identifiants
pubmed: 37482020
pii: S0223-5234(23)00621-9
doi: 10.1016/j.ejmech.2023.115655
pii:
doi:
Substances chimiques
Enzyme Inhibitors
0
Monophenol Monooxygenase
EC 1.14.18.1
Triazoles
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
115655Informations de copyright
Copyright © 2023 Elsevier Masson SAS. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.